ID   NT2.5
AC   CVCL_JA60
DR   GEO; GSM1155324
DR   Wikidata; Q54931105
RX   PubMed=18829490;
RX   PubMed=19642106;
CC   Genetic integration: Method=Transgenic mouse; Gene=RGD; 2561; Erbb2.
CC   Omics: Transcriptomics; Microarray.
CC   Breed/subspecies: FVB/N-Tg(MMTVneu)202Mul/J transgenic.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_JA57 ! NT2
SX   Female
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 5
//
RX   PubMed=18829490; DOI=10.1158/1078-0432.CCR-07-4672; PMCID=PMC2570093;
RA   Song H., Shahverdi K., Huso D.L., Wang Y.-C., Fox J.J., Hobbs R.F.,
RA   Gimi B., Gabrielson K.L., Pomper M.G., Tsui B.M., Bhujwalla Z.,
RA   Reilly R.T., Sgouros G.;
RT   "An immunotolerant HER-2/neu transgenic mouse model of metastatic
RT   breast cancer.";
RL   Clin. Cancer Res. 14:6116-6124(2008).
//
RX   PubMed=19642106; DOI=10.1002/ijc.24780;
RA   Lau W.M., Weber K.L., Doucet M., Chou Y.-T., Brady K., Kowalski J.,
RA   Tsai H.-L., Yang J., Kominsky S.L.;
RT   "Identification of prospective factors promoting osteotropism in
RT   breast cancer: a potential role for CITED2.";
RL   Int. J. Cancer 126:876-884(2010).
//